Status:
COMPLETED
Intraoperative Simultaneous Pressure Guided Revascularization Study
Lead Sponsor:
Mark Rockley
Conditions:
Peripheral Vascular Diseases
Blood Pressure
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to determine whether intraoperative physiologic measurements of blood flow to the leg during endovascular treatment of Peripheral Arterial Disease (PAD) can predict future clinical out...
Detailed Description
Lower extremity peripheral arterial disease (PAD) caused by atherosclerosis can cause cause leg pain, gangrene, and limb loss. PAD is a result of poor blood flow to the extremity, and the emerging mos...
Eligibility Criteria
Inclusion
- Patients undergoing elective or semi-urgent endovascular procedures on lesions of the aorta, iliac, femoral, popliteal, or tibial arteries
- Symptomatic, atherosclerotic Peripheral Vascular Disease. These symptoms include any Rutherford's classification.
Exclusion
- Concurrent hybrid open procedure during endovascular revascularization requiring vascular clamping for any period of time, such as endarterectomy
- Prior open vascular surgery performed on the affected leg
- Emergent intervention for Acute Limb Ischemia, defined as symptoms lasting less than 14 days
- Non-femoral vascular access
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03875846
Start Date
October 1 2018
End Date
January 1 2021
Last Update
August 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital, Civic Campus
Ottawa, Ontario, Canada, K1Y 4E9